Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 10:06 am Sale |
2022-12-31 | 13G | La Jolla Pharmaceutical Company LJPC |
RTW Investments, LP | 0 0.000% |
-2,590,932 (Position Closed) |
Filing History |
| 2022-08-29 12:30 pm Sale |
2022-08-23 | 13D | La Jolla Pharmaceutical Company LJPC |
GARDNER LEWIS ASSET MANAGEMENT L P | 0 0.000% |
-1,504,791 (Position Closed) |
Filing History |
| 2022-08-29 12:07 pm Purchase |
2022-08-16 | 13D | La Jolla Pharmaceutical Company LJPC |
GARDNER LEWIS ASSET MANAGEMENT L P | 1,504,791 6.000% |
1,504,791 (New Position) |
Filing History |
| 2022-08-24 4:00 pm Sale |
2022-08-22 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-9,959,934 (Position Closed) |
Filing History |
| 2022-07-11 6:15 pm Unchanged |
2022-07-10 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 9,959,934 39.800% |
0 (Unchanged) |
Filing History |
| 2022-02-14 09:26 am Purchase |
2021-12-31 | 13G | La Jolla Pharmaceutical Company LJPC |
RTW Investments, LP | 2,590,932 9.300% |
193,554 (+8.07%) |
Filing History |
| 2021-12-02 08:30 am Sale |
2021-12-01 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 9,959,934 36.000% |
-166,270 (-1.64%) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | La Jolla Pharmaceutical Company LJPC |
BLACKROCK INC BLK |
384,695 1.400% |
-1,092,804 (-73.96%) |
Filing History |
| 2021-05-27 06:03 am Purchase |
2021-05-26 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 10,126,204 36.800% |
410,714 (+4.23%) |
Filing History |
| 2021-02-12 09:26 am Sale |
2020-12-31 | 13G | La Jolla Pharmaceutical Company LJPC |
RTW Investments, LP | 2,397,378 8.750% |
-153,642 (-6.02%) |
Filing History |
| 2021-01-29 5:23 pm Sale |
2020-12-31 | 13G | La Jolla Pharmaceutical Company LJPC |
BLACKROCK INC BLK |
1,477,499 5.400% |
-96,837 (-6.15%) |
Filing History |
| 2021-01-04 11:15 am Sale |
2021-01-04 | 13G | La Jolla Pharmaceutical Company LJPC |
Broadfin Capital LLC | 0 0.000% |
-2,688,068 (Position Closed) |
Filing History |
| 2020-09-11 06:02 am Purchase |
2020-09-09 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 9,715,490 35.400% |
278,369 (+2.95%) |
Filing History |
| 2020-08-18 06:05 am Purchase |
2020-08-14 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 9,437,121 34.400% |
431,647 (+4.79%) |
Filing History |
| 2020-07-29 5:18 pm Purchase |
2020-07-28 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
7,263,236 100.000% |
6,178,236 (+569.42%) |
Filing History |
| 2020-06-30 5:37 pm Unchanged |
2020-06-29 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
1,085,000 14.900% |
0 (Unchanged) |
Filing History |
| 2020-06-25 9:58 pm Unchanged |
2020-06-24 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
1,085,000 14.900% |
0 (Unchanged) |
Filing History |
| 2020-06-22 5:17 pm Purchase |
2020-06-15 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
1,085,000 14.900% |
1,085,000 (New Position) |
Filing History |
| 2020-06-05 06:04 am Purchase |
2020-06-02 | 13D | La Jolla Pharmaceutical Company LJPC |
TANG CAPITAL PARTNERS LP | 9,005,474 32.900% |
784,899 (+9.55%) |
Filing History |